- Austin TX, US David E. GERBER - Dallas TX, US Quan LI - Dallas TX, US Shaheen KHAN - Dallas TX, US Saad KHAN - Dallas TX, US Yang XIE - Dallas TX, US Jason Y. Park - Dallas TX, US Farjana FATTAH - Dallas TX, US Xin LUO - Dallas TX, US
Assignee:
The Board of Regents of the University of Texas System - Austin TX
International Classification:
G01N 33/68 G01N 33/564 C07K 16/28
Abstract:
The present disclosure is directed to methods and compositions for the prediction and treatment of immunotherapy—induced toxicities, as well as improved methods for the treatment of cancer with immunotherapies.
Prediction And Treatment Of Immunotherapeutic Toxicity
- Austin TX, US Edward WAKELAND - Dallas TX, US Quan LI - Dallas TX, US Saad KHAN - Dallas TX, US Jason Y. PARK - Dallas TX, US Xin LUO - Dallas TX, US Yang XIE - Dallas TX, US
Assignee:
The Board of Regents of the University of Texas System - Austin TX
International Classification:
G01N 33/68 C07K 16/28
Abstract:
The present disclosure is directed to methods and compositions for the prediction and treatment of immunotherapy-induced toxicities, as well as improved methods for the treatment of cancer with immunotherapies.